Intensive insulin therapy versus plasmapheresis in the management of hypertriglyceridemia-induced acute pancreatitis (Bi-TPAI trial): study protocol for a randomized controlled trial

Intensive insulin therapy versus plasmapheresis in the management of hypertriglyceridemia-induced acute pancreatitis (Bi-TPAI trial): study protocol for a randomized controlled trial

Abstract Background It is widely agreed that triglyceride (TG)-lowering therapy is imperative in early hypertriglyceridemia-induced acute pancreatitis (HTG-AP). Intravenous insulin with or without heparin, and plasmapheresis are available regimens. However, there is no consensus on first-line therap...

Full description

Bibliographic Details
Main Authors: Xiao Song, Di Shi, Qinghong Cui, Shanshan Yu, Jing Yang, Priscilla Song, Joseph Walline, Jun Xu, Huadong Zhu, Xuezhong Yu
Format: Article
Language:English
Published: BMC 2019-06-01
Series:Trials
Subjects:
Hypertriglyceridemia-induced acute pancreatitis
Insulin
Plasmapheresis
Triglyceride-lowering
Online Access:http://link.springer.com/article/10.1186/s13063-019-3498-x

Internet

http://link.springer.com/article/10.1186/s13063-019-3498-x

Similar Items